Assuntina Sacco, M.D.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer (NCT02875613) | Assuntina Sacco, M.D. | 2017-01-01 |
Track Assuntina Sacco, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.